ArticleDiabetes spectrum : a publication of the American Diabetes Association2025
Meta-Analytic Insights Into Mindfulness Approaches for Depression and Diabetes Comorbidity Care.
Article in Diabetes spectrum : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study evaluated the effectiveness of mindfulness-based interventions (MBIs) in managing comorbid depression and diabetes by assessing their efficacy in reducing depressive symptoms and improving glycemic control, while addressing inconsistencies in existing research. RESEARCH DESIGN AND
methodsA systematic review and meta-analysis were conducted of 17 randomized controlled trials published between 2013 and 2024 and involving 1,336 participants with diabetes and depressive symptoms. Effect sizes were calculated using Hedges'
resultsMBIs significantly reduced depressive symptoms (standardized mean difference [SMD] -0.88, 95% CI -1.34 to -0.42) with high heterogeneity (
conclusionMBIs are effective in reducing depressive symptoms and improving glycemic control in individuals with comorbid diabetes and depression. These findings highlight the importance of culturally adapted approaches and call for further research to refine MBI applications in diabetes care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.